title: EQ-5D Scores In Patients Receiving Tolvaptan for the Treatment Of Hyponatraemia Secondary to the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
authors.affiliation: Decision Resources Group, London, UK.
authors.forename: D
authors.initials: D
authors.lastname: Trueman
authors.affiliation: Decision Resources Group, London, UK.
authors.forename: E
authors.initials: E
authors.lastname: Hancock
authors.affiliation: Otsuka Pharmaceutical Europe Ltd, Wexham, UK.
authors.forename: P
authors.initials: P
authors.lastname: Robinson
authors.affiliation: Otsuka Pharmaceutical Europe Ltd, Wexham, UK.
authors.forename: P
authors.initials: P
authors.lastname: Dale
authors.affiliation: Otsuka Pharmaceutical Europe Ltd, Wexham, UK.
authors.forename: K
authors.initials: K
authors.lastname: O'Reilly
authors.affiliation: Otsuka Pharmaceutical Europe Ltd, Wexham, UK.
authors.forename: M
authors.initials: M
authors.lastname: Gisby